Literature DB >> 1091552

Effects of human and rabbit serum on viability, permeability, and envelope lipids of Serratia marcescens.

S Beckerdite-Quagliata, M Simberkoff, P Elsbach.   

Abstract

The major action of serum on gram-negative organisms is thought to be on the microbial envelope. We compared the effects of normal human and rabbit serum on the envelope lipids of two strains of Serratia marcescens, one sensitive and one resistant to the bactericidal effects of serum. During killing by either serum, the sensitive strain underwent rapid permeability changes coincident with degradation of microbial phospholipids. The resistant strain exhibited none of these effects. The phospholipid degradation that accompanies killing of the sensitive strain by serum could be caused by phospholipases present in serum or by Serratia's own phospholipid-splitting enzymes. The results indicate that phospholipid breakdown is caused by activation of bacterial of bacterial phospholipases and not by serum phospholipases. This conclusion is based upon the following findings.(i1 Although rabbit serum phospholipase A was at least 10 times more active than human serum phospholipase A, phospholipid degradation in the sensitive Serratia strain was comparable during (equally rapid) killing by human or rabbit serum. (ii) Heat treatment (56 C) of both sera eliminated bactericidal activity as well as microbial lipid degradation but abolished phospholipase activity of human serum only. (iii) Virtually complete removal of phospholipase A activity from human serum by adsorption onto autoclaved Micrococcus lysodeikticus had no effect on the extent of phospholipid hydrolysis or on bactericidal activity. Activation by serum of endogenous phospholipase activity in S. marcescens was accompanied by enhanced incorporation of lipid precursors into bacterial lipids. No evidence was found for increased turnover of protein or ribonucleic acid during killing by serum.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1091552      PMCID: PMC415134          DOI: 10.1128/iai.11.4.758-766.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Some properties of phospholipases of alveolar macrophages.

Authors:  R Franson; S Beckerdite; P Wang; M Waite; P Elsbach
Journal:  Biochim Biophys Acta       Date:  1973-02-14

2.  Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction.

Authors:  D S Feingold; J N Goldman; H M Kuritz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

3.  [Presence of phospholipase precursor in normal human serum].

Authors:  J Etienne; M Paysant; A Grüber; J Polonovski
Journal:  Bull Soc Chim Biol (Paris)       Date:  1969-09-18

4.  Distribution of phospholipid-synthesizing enzymes in the wall and membrane subfractions of the envelope of Escherichia coli.

Authors:  D A White; F R Albright; W J Lennarz; C A Schnaitman
Journal:  Biochim Biophys Acta       Date:  1971-12-03

5.  Effects of levorphanol on phospholipid metabolism and composition in Escherichia coli.

Authors:  N Wurster; P Elsbach; J Rand; E J Simon
Journal:  Biochim Biophys Acta       Date:  1971-11-05

6.  Characteristics of complement-dependent release of phospholipid from Escherichia coli.

Authors:  L A Wilson; J K Spitznagel
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

7.  Increased synthesis of phospholipid during phagocytosis.

Authors:  P Elsbach; S Levy
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

8.  Interrelationship between serum beta-lysin, lysozyme, and the antibody-complement system in killing Escherichia coli.

Authors:  D M Donaldson; R R Roberts; H S Larsen; J G Tew
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

9.  Persistence of regulation of macromolecular synthesis by Escherichia coli during killing by disrupted rabbit granulocytes.

Authors:  P Elsbach; S Beckerdite; P Pettis; R Franson
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

10.  Early and discrete changes in permeability of Escherichia coli and certain other gram-negative bacteria during killing by granulocytes.

Authors:  S Beckerdite; C Mooney; J Weiss; R Franson; P Elsbach
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  9 in total

1.  Effect of serum on phospholipids of L-forms of Streptococcus faecalis.

Authors:  J Z Montgomerie; D Kaplan; M Schotz; L B Guze
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

Review 2.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

3.  Killing of gram-negative bacteria by polymorphonuclear leukocytes: role of an O2-independent bactericidal system.

Authors:  J Weiss; M Victor; O Stendhal; P Elsbach
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

4.  Plasmid-mediated resistance to the bactericidal effects of normal rabbit serum.

Authors:  A M Reynard; M E Beck
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

5.  Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.

Authors:  Y Weinrauch; C Abad; N S Liang; S F Lowry; J Weiss
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

6.  Role of bacterial phospholipases in serum-mediated killing of Escherichia coli.

Authors:  D L Kreutzer; M Vandermaten; C S Buller; D C Robertson; A A Hirata
Journal:  Infect Immun       Date:  1977-10       Impact factor: 3.441

7.  Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.

Authors:  J E Leggett; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

8.  Membrane changes induced by exposure of Escherichia coli to human serum.

Authors:  H P Kroll; S Bhakdi; P W Taylor
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

9.  Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.

Authors:  K A Joiner; C H Hammer; E J Brown; R J Cole; M M Frank
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.